Embozene Color-Advanced Microspheres
FDA 510(k) K180102 · Boston Scientific
510(k) numberK180102
Submission
- Device name
- Embozene Color-Advanced Microspheres
- Applicant
- Boston Scientific
Maple Grove, MN, US - Received
- January 16, 2018
- Decision date
- April 19, 2018
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- NOY – Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 876.5550
- Specialty
- Gastroenterology, Urology
- Implant
- Yes
The device comprises one or more objects placed in a blood vessel to permanently obstruct blood flow to the prostate to treat benign prostatic hyperplasia (BPH).
Other 510(k)s with product code NOY
More from MicroVention, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K262151 | SpaceOAR Flex SystemOVB · Traditional | 09/11/2026SE |
| K262460 | Rezum SystemKNS · Traditional | 09/03/2026SE |
| K261153 | LithoVue Elite Digital Flexible Ureteroscope SystemFGB · Traditional | 08/26/2026SE |
| K253692 | AVVIGO+ Multi-Modality Guidance SystemDQK · Traditional | 08/21/2026SE |
| K262406 | EluPro Antibiotic-Eluting BioEnvelopeFTM · Special | 08/12/2026SE |
| K261915 | Navigator Flex Ureteral Access Sheath SetFED · Traditional | 08/04/2026SE |
| K262462 | TheraSphere 360 Y-90 Management PlatformLLZ · Special | 07/24/2026SE |
| K262165 | FARADRIVE Steerable Sheath (M004PF21M402)DRA · Special | 07/24/2026SE |
| K261488 | OBSIDIO Conformable EmbolicKRD · Traditional | 07/24/2026SE |
| K261978 | WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent SystemESW · Special | 07/10/2026SE |
Questions and answers
When was Embozene Color-Advanced Microspheres cleared by the FDA?
Embozene Color-Advanced Microspheres (K180102) received a 510(k) decision of Substantially Equivalent on April 19, 2018, 93 days after the submission was received.
What is the product code of K180102?
The FDA product code is NOY – Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia, a Class II (moderate risk) device regulated under 21 CFR 876.5550.